Larry S. Schlesinger
About Larry S. Schlesinger
Larry S. Schlesinger is a distinguished expert in infectious diseases and the President and CEO of Texas Biomed, known for his significant contributions to tuberculosis research and lung biology.
Larry S. Schlesinger: President and CEO of Texas Biomed
Larry S. Schlesinger serves as the President and Chief Executive Officer of Texas Biomed. He has held this position since 2017, leading a transformational strategic planning process that has significantly impacted the institute. Under his leadership, Texas Biomed has formed robust relationships and innovative partnerships with various organizations including UT Health San Antonio, the Southwest Research Institute, and the University of Texas at San Antonio, as well as other colleges and universities in the region. Additionally, Schlesinger has connected Texas Biomed with the private sector biomedical landscape, fostering a collaborative environment for scientific advancement.
Expertise in Infectious Diseases and Tuberculosis
Larry S. Schlesinger is an internationally recognized authority in infectious diseases, with a particular focus on tuberculosis and lung biology. He has been at the forefront of research in these fields, consistently receiving funding from the NIH and other agencies for three decades. Schlesinger has authored more than 200 peer-reviewed articles, reviews, and chapters in leading textbooks on these subjects. His research primarily investigates the pathogenesis of tuberculosis and other airborne infectious agents that subvert lung immune mechanisms. Additionally, he is a Principal Investigator for several ongoing research grants, including the Southwest National Primate Research Center Base Grant.
Educational Background and Academic Positions
Larry S. Schlesinger earned a BA in Biology from Cornell University and an MD from Rutgers Medical School. He completed his residency in Internal Medicine at the University of Michigan, followed by clinical and research fellowships in Infectious Diseases at UCLA. Schlesinger began his academic career at the University of Iowa in 1991, where he served as Fellowship Director for the Division of Infectious Diseases and Associate Chair of the Department of Medicine. In 2002, he moved to Ohio State University, taking on the role of Director of the Division of Infectious Diseases and later becoming the first chair of Microbial Infection & Immunity. At Ohio State, he also founded the Center for Microbial Interface Biology, now known as the Infectious Diseases Research Institute.
Larry S. Schlesinger's Contributions and Recognitions
Throughout his career, Larry S. Schlesinger has made significant contributions to the field of infectious diseases. He has been a member or chair of several NIH study sections and other private and federal agencies. Schlesinger's work has been recognized by numerous professional organizations; he is a Fellow of the AAAS, American Academy of Microbiology, American Association of Physicians, and the Infectious Diseases Society of America. In 2018, the San Antonio Business Journal named him a Healthcare Hero in the area of Outstanding Medical Researcher. Schlesinger also plays an active role in the scientific community, serving on the Boards of Biomed SA and the SA Medical Foundation.
Commitment to Education and Mentorship
Larry S. Schlesinger has placed significant emphasis on education and mentorship throughout his career. As a Professor at Texas Biomed, he has been dedicated to fostering the growth of clinical and translational research. Schlesinger has mentored numerous students and professionals in the field, imparting valuable knowledge and skills essential for their careers in biomedical sciences. His commitment to education is evident in his ongoing involvement in various advisory boards for universities, the NIH, and the FDA, among others. Schlesinger's efforts have helped shape the next generation of scientists and researchers, contributing to advancements in the understanding and treatment of infectious diseases.